Partial Epilepsy
📧 Sign up to get email alerts when something new happens for Partial Epilepsy.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-20EMA Authorised: Lacosamide UCB (lacosamide) — UCB Pharma S.A.
EMA authorises lacosamide (Lacosamide UCB) for partial epilepsies in EU.
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Update: Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures [Phase 3]
A Phase 3 clinical trial evaluates cenobamate for safety and efficacy in pediatric subjects aged 2-17 with partial-onset seizures; study sta…
-
EMA approval · 2026-07-22EMA Authorised: Kigabeq (vigabatrin) — ORPHELIA Pharma
EMA has authorised Kigabeq (vigabatrin) for infantile spasms and partial epilepsies, with ORPHELIA Pharma as the marketing authorization hol…
-
EMA approval · 2026-07-10EMA Authorised: Fycompa (perampanel) — Eisai GmbH
The EMA authorises Fycompa (perampanel) for partial epilepsies in Europe, with Eisai GmbH as the marketing authorization holder.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures [Phase 3]
A Phase 3 safety and efficacy study of cenobamate (Xcopri) in pediatric patients aged 2-17 with partial-onset seizures is currently active b…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: High-resolution Multi-parametric Magnetic Resonance Imaging for Focal Epilepsy [NA]
This clinical trial update notes a study from the Chinese University of Hong Kong evaluating high-resolution multi-parametric magnetic reson…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Transcranial Direct Current to Treat Epilepsy at Home [NA]
A Stanford University–sponsored trial is evaluating home-based transcranial direct current stimulation as a treatment for partial epilepsy; …
-
EMA approval · 2026-02-19EMA Authorised: Kigabeq (vigabatrin) — ORPHELIA Pharma
The EMA has authorised Kigabeq (vigabatrin) by ORPHELIA Pharma for infantile spasms and partial epilepsies.
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: National Network for the Study of Predictors and Prevention of Sudden Unexpected Death in Drug-resistant Partial Epilepsies
Clinical trial conducted by Hospices Civils de Lyon on predictors and prevention of sudden unexpected death in drug-resistant partial epilep…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Recording "Fast Ripples" Using Microelectrodes During Stereo-encephalography in Patients With Drug-resistant Partial Epilepsy [NA]
A completed clinical trial evaluating recording fast ripples with microelectrodes during stereo-encephalography in people with drug-resistan…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW) [Phase 4]
A Phase 4 trial comparing low versus standard daily doses of antiepileptic drugs in newly diagnosed, previously untreated epilepsy. Results …
-
EMA approval · 2025-05-23EMA Authorised: Lacosamide UCB (lacosamide) — UCB Pharma S.A.
The European Medicines Agency authorised a lacosamide product (Lacosamide UCB) from UCB Pharma S.A., for partial epilepsy.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures [Phase 4]
Phase 4 clinical study evaluating zonisamide as a first add-on therapy for epileptic seizures. The study is currently recruiting at Affiliat…
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies [NA]
This completed clinical trial investigated the contribution of genetics, non-invasive methods, and neuropsychology in focal cryptogenic epil…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Thermocoagulation in Drug Resistant Focal Epilepsy [NA]
This ClinicalTrials.gov entry describes a study of thermocoagulation for drug-resistant focal epilepsy; the trial is currently active but no…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Cerebral Oxygen Saturation and Cytochrome Oxidase REDOX State in Children With Epilepsy: A Pilot Study
A completed pilot trial assessing cerebral oxygen saturation and cytochrome oxidase redox state in children with partial epilepsy.
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Treating Postictal Symptoms Using Ibuprofen and Nifedipine [Phase 2]
A Phase 2 clinical trial sponsored by the University of Calgary is evaluating the combination of ibuprofen and nifedipine to treat postictal…
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures [Phase 2]
A Phase 2 randomized trial of ganaxolone in adults with uncontrolled partial-onset seizures has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Open-label Extension to Protocol 1042-0600 [Phase 2]
Open-label extension study update for a Phase 2 trial in partial epilepsies; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures [Phase 2]
Phase 2 double-blind, randomized, placebo-controlled trial evaluating YKP3089 as adjunctive therapy for partial onset seizures; results were…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures [Phase 2]
Phase 2 trial update on YKP3089 for treatment-resistant partial onset seizures; results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy [Phase 3]
Phase 3 trial results for deep brain stimulation of the anterior nucleus of the thalamus in partial epilepsy have been completed.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Phase II BGG492 Capsule Extension for Partial Epilepsy [Phase 2]
Phase II extension trial update for BGG492 capsule in partial epilepsy (partial onset seizures) completed.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy [NA]
Clinical trial update evaluating fluoxetine for reducing ictal hypoventilation in patients with uncontrolled partial epilepsy has completed …
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: PRX-00023 Therapy in Localization-Related Epilepsy [Phase 2]
Phase 2 trial update for PRX-00023 in localization-related epilepsy (temporal lobe). Trial status terminated; results posted in 2018.